{"product_id":"the-renaissance-of-cancer-immunotherapy-isbn-9781573318952","title":"The Renaissance of Cancer Immunotherapy","description":"\u003cp\u003eThis \u003ci\u003eAnnals\u003c\/i\u003e volume includes invited short reviews on topics presented at the 7th International Cancer Vaccine Symposium “Renaissance of Cancer Immunotherapy”, held September 9-11, 2012 in Florence, Italy.  The papers cover the latest progress in basic immunology research and its translation to cancer patients.  The meeting and papers pay tribute to the successes in the last few years that have led to the approval of new immunotherapies and the awarding of the Nobel Prize in medicine to three immunologists.  The symposium is dedicated to one of these recipients, Dr. Ralph Steinman who discovered dendritic cells, immune cells that are vital in immune responses and immunotherapies for cancer.\u003cbr\u003e\u003cbr\u003eNOTE: \u003ci\u003eAnnals\u003c\/i\u003e volumes are available for sale as individual books or as a journal. For more information on institutional journal subscriptions, please visit: http:\/\/ordering.onlinelibrary.wiley.com\/subs.asp?ref=1749-6632\u0026amp;doi=10.111\/(ISSN)1749-6632\u003c\/p\u003e \u003cp\u003eACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order http:\/\/www.nyas.org\/. Members of the New York Academy of Science receive full-text access to \u003ci\u003eAnnals\u003c\/i\u003e online and discounts on print volumes. Please visit http:\/\/www.nyas.org\/MemberCenter\/Join.aspx for more information on becoming a member.\u003c\/p\u003e \u003cp\u003eIntroduction to The Renaissance of Cancer Immunotherapy v\u003cbr\u003e\u003ci\u003eOlivera J. Finn and Gerold Schuler\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eCancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy 1\u003cbr\u003e\u003ci\u003eMatthews D. Vesely and Robert D. Schreiber\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eCell-extrinsic effects of the tumor unfolded protein response on myeloid cells and T cells 6\u003cbr\u003e\u003ci\u003eMaurizio Zanetti\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eImmunotherapy in preneoplastic disease: targeting early procarcinogenic inflammatory changes that lead to immune suppression and tumor tolerance 12\u003cbr\u003e\u003ci\u003eBridget Keenan and Elizabeth M. Jaffee\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntegration of epidemiology, immunobiology, and translational research for brain tumors 17\u003cbr\u003e\u003ci\u003eHideho Okada, Michael E. Scheurer, Saumendra N. Sarkar, and Melissa L. Bondy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eHuman dendritic cells subsets as targets and vectors for therapy 24\u003cbr\u003e\u003ci\u003eEynav Klechevsky and Jacques Banchereau\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDendritic cell immunotherapy 31\u003cbr\u003e\u003ci\u003eRachel Lubong Sabado and Nina Bhardwaj\u003c\/i\u003e\u003cbr\u003e\u003cbr\u003eMolecular programming of steady-state dendritic cells: impact on autoimmunity and tumor immune surveillance 46\u003cbr\u003e\u003ci\u003eDylan J. Johnson and Pamela S. Ohashi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003ePreventing cancer by targeting abnormally expressed self-antigens: MUC1 vaccines for prevention of epithelial adenocarcinomas 52\u003cbr\u003e\u003ci\u003ePamela L. Beatty and Olivera J. Finn\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eImmunological control of cell cycle aberrations for avoidance of oncogenesis: the case of tetraploidy 57\u003cbr\u003e\u003ci\u003eLaura Senovilla, Lorenzo Galluzzi, Maria Castedo, and Guido Kroemer\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOngoing adaptive immune responses in the microenvironment of melanoma metastases 62\u003cbr\u003e\u003ci\u003eNicolas van Baren and Pierre G. Coulie\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eMain features of human T helper 17 cells 66\u003cbr\u003e\u003ci\u003eFrancesco Annunziato, Lorenzo Cosmi, Francesco Liotta, Enrico Maggi, and Sergio Romagnani\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIn silico modeling of cancel cell dissemination and metastasis 71\u003cbr\u003e\u003ci\u003eLu-En Wai, Vipin Narang, Alexandre Gouaillard, Lai Guan Ng, and Jean-Pierre Abastado\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eCommon pathways to tumor rejection 75\u003cbr\u003e\u003ci\u003eEna Wang, Davide Bedognetti, Sara Tomei, and Francesco M. Marincola\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eCancer-induced immunosuppressive cascades and their reversal by molecular-targeted therapy 80\u003cbr\u003e\u003ci\u003eYutaka Kawakami, Tomonori Yaguchi, Hidetoshi Sumimoto, Chie Kudo-Saito, Nobuo Tsukamoto. Tomoko Iwata-Kajihara, Shoko Nakamura, Hiroshi Nishio, Ryosuke Satomi, Asuka Kobayashi, Mayuri Tanaka, Jeong Hoon Park, Hajime Kamijuku, Takahiro Tsujikawa, and Naoshi Kawamura\u003c\/i\u003e\u003c\/p\u003e  \u003cp\u003eOlivera J. Finn is a Yugoslav-American immunologist who is a distinguished professor and former chair of the Department of Immunology at the University of Pittsburgh and former director of the Cancer Immunology Program at the University of Pittsburgh Cancer Institute. Gerold Schuler is the editor of The Renaissance of Cancer Immunotherapy: The 7th International Cancer Vaccine Symposium, Volume 1284, published by Wiley.\u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47990328819941,"sku":"NP9781573318952","price":144.5,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781573318952.jpg?v=1761787379","url":"https:\/\/k12savings.com\/products\/the-renaissance-of-cancer-immunotherapy-isbn-9781573318952","provider":"K12savings","version":"1.0","type":"link"}